Solutions based on Artificial Intelligence (AI) to support the Diabetic Retinopathy process in the field of primary care

The Integral Health System of Public Use of Catalonia (SISCAT) is running an open market consultation aimed to capture the availability on the market, or the possibilities that the market can develop, of solutions based on Artificial Intelligence (AI) to support the process of Diabetic Retinopathy, integrated and interoperable in the field of primary care.

Diabetic Retinopathy (DR) is a neurovascular complication for type 1 and 2 diabetic patients that can lead to reduced or complete loss of vision. The main benefits that are intended to be achieved with the future implementation of these solutions are:

  • improving current screenings,
  • increasing population coverage and personalizing intervals between tests according to the risk conditions of patients;
  • reducing inter consultations with the ophthalmologist to resolve dubious cases;
  • detecting in advance the number of serious injuries,
  • reducing the number of treatments related to these avoided injuries;
  • avoiding population displacement to centres screening.

This procedure is part of the Recovery, Transformation and Resilience Plan - Funded by the European Union – NextGenerationEU.

An event will take place in Barcelona on 9 January 2023 to explain how the market consultation will be developed. The event can be followed remotely or in person. It is necessary to specify the mode of attendance when booking the ticket (Presentació de la consulta oberta al mercat: Repte Retinopatia Diabètica Entradas, Lun, 9 ene. 2023 a las 12:00 | Eventbrite). In case of booking the remote modality, the link will be sent to the indicated email address a few hours before the event.

Please not that all the information and communication with the interested economic operators will be in Spanish and Catalan.

Date: 19/12/2022 | Tag: | News: 1400 of 1573
All news


More news


More events

Subscribe to the VPH Institute Newsletter


Read all the newsletters of the VPH Institute